To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence.
Additional recommended knowledge
Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. It thereby decreases the urgency to urinate. It should not be used in people with urinary retention.
It is not known whether this selectivity for the M3 receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome.(1)
Darifenacin is administered as a once-daily extended-release oral tablet.
(1) SPC for emselex-revised on 29/11/06 (available at www.medicines.org.uk)
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Darifenacin". A list of authors is available in Wikipedia.|